Find out how we're leveraging AI to empower you to accelerate your science
Signals One™
Science is getting more complex. Simplify it with Signals One™.
Make your innovations a reality with the first unified, cloud-native SaaS R&D solution that streamlines scientific complexity and promotes collaboration
Coming in Signals One:
- Simply handle common visualization and analytics use cases, including in vitro curve fitting, in vivo data visualization, and group-comparison
- Enhance user experience and ensure IP protection with integrated Generative AI and LLM
- Create and use ontologically aware assay repositories that follow F.A.I.R. data principles
An introduction to Signals One
Signals One is an end-to-end R&D workflow solution providing data capture & collaboration, data processing, and data-driven analytics.
Signals Connect
Join us for this ongoing Signals Connect community series and learn how you can go beyond and get more out of your data using Signals One. Gain critical insights to accelerate your R&D discoveries.
-
Unlock innovation with Signals One
Read the Data SheetAI-enhanced Signals One empowers researchers by providing a cloud-native, unified software platform that spans the entire Design-Make-Test-Decide R&D lifecycle. Collaborate seamlessly across R&D disciplines, adapt to real-time experimental planning and laboratory bench work, and make informed decisions based on comprehensive data analysis to accelerate innovation in bringing products to market.
-
Increase the success rate for your drug discovery
Read NowAI-enhanced Signals One gives more scientific quality time to medicinal and synthetic chemists, improving their chances of successfully bringing new therapeutics to market. The only chemistry software solution powered by ChemDraw and Spotfire, Signals One delivers research depth for medicinal chemistry and new drug modalities while fostering unified breadth of collaboration in multidisciplinary workflow.
-
Promoting collaboration between multidisciplinary teams
Read NowAI-enhanced Signals One gives biologists complete control of their workflows across every assay technique, modality, and data type to empower better interaction between multidisciplinary project teams. Whatever the nature of your drug discovery program, Signals One can help you bring your scientific breakthroughs to patients faster.
-
One Solution for Design-Make-Test-Decide
Read NowAI-enhanced Signals One offers top-tier analysis and data visualization throughout the Design-Make-Test-Decide R&D lifecycle. It fosters rapid innovation in the discovery, development, and optimization of biological and chemical modalities, accelerating their journey to market.
Signals One has given Cogent Biosciences the kind of data analytics capabilities that were once the sole domain of big pharma companies with deep pockets and extensive IT departments.
Small Molecule Drug Discovery |
||
|---|---|---|
|
Capabilities |
Description |
Benefits |
|
Compound Synthesis |
Streamlines the process of designing, planning and documenting chemical reactions.
|
|
|
Compound Analysis |
Researchers can efficiently make test requests, evaluate and interpret experimental data related to chemical compounds. |
|
|
Compound Registration |
Enables researchers to efficiently input, manage, and analyze chemical compound data through.
|
|
|
Empowers researchers to efficiently discover and evaluate potential drug candidates through:
|
|
|
|
in vitro analysis |
Developing assays to measure cell activity, processing assay data, visualizing assay results, and analyzing assays using High Content Screening (HCS) and Surface Plasmon Resonance (SPR) |
|
|
Lead Optimization |
Self-service analytics and visualization tools to refine promising drug candidates to enhance drug efficacy, safety, and pharmacokinetics properties.
|
|
|
Efficacy and Toxicology Studies |
Evaluate biological effects and potential toxicities in animal models through comprehensive data analysis and streamlined reporting workflows |
Predict treatment outcomes and identify potential adverse events at the preclinical stage, thereby reducing risks and enabling the optimization of the drug candidate’s therapeutic profile before clinical trials |
|
Pharmacokinetics and Pharmacodynamics |
Analyze and model PK/PD profiles to assess how a drug behaves in biological systems |
Gain critical insights empowered by Spotfire® into drug safety, ADME and optimal dosing, helping to optimize clinical trial designs and maximize the likelihood of success in late-stage development. |
|
Biomarker Discovery |
Identification and validation of biomarkers to measure effects of drug candidates |
|
Biologics Discovery |
||
|---|---|---|
|
Capabilities |
Description |
Benefits |
|
Biologics Registration |
Create biological modality libraries easily to track and connect relevant datasets
|
Centralizes all drug modality material assets, improving data accessibility and reducing duplication, thereby enhancing efficiency in research workflows |
|
Assays |
Build, define and manage biological assay workflows
|
Streamlines assay processes, enhances reproducibility, and reduces time-to-data for decision-making, leading to more efficient experimental outcomes |
|
Results Analysis |
Access to key datasets quickly within experimental, project, and program contexts
|
Accelerates identification of key patterns and trends, enabling faster hypothesis validation and data-driven decisions, ultimately advancing research objectives |
|
Hit Identification |
Empowers researchers to efficiently discover and evaluate potential drug candidates through:
|
|
|
in vitro analysis |
Developing assays to measure cell activity, processing assay data, visualizing assay results, and analyzing assays using High Content Screening (HCS) and Surface Plasmon Resonance (SPR) |
|
|
Lead Optimization |
Optimize lead compounds by integrating multi-parameter datasets, predictive modeling, and workflow automation to refine drug candidates
|
|
|
Pharmacokinetics and Pharmacodynamics |
Analyze and model PK/PD profiles to assess how a drug behaves in biological systems, enabling dosing strategies |
Mitigate late-stage failures by predicting human responses early in the development pipeline, saving time and resources |
|
Efficacy and Toxicology Studies |
Evaluate biological effects and potential toxicities in animal models through comprehensive data analysis and streamlined reporting workflows |
Predict treatment outcomes and identify potential adverse events at the preclinical stage, thereby reducing risks and enabling the optimization of the drug candidate’s therapeutic profile before clinical trials |
Related Products
SignalsNotebook
The premier cloud-based electronic lab notebook for biologists and chemists to collaborate, capture, organize, share, and explore data.
Learn More
SignalsSynergy
Enhancing collaboration and information exchange between Sponsors and CROs.
Learn MoreScitara DLX
Streamline workflows with Revvity Signals and Scitara DLX. Enable rapid integration, unifying lab ecosystems for improved productivity.
Learn MoreLead Discovery Premium
Analyze and visualize chemical structure & biological sequence SAR data. Compare and score segment leads based on multi-parametric optimization.
Learn MoreRelated Events & Webinars
Resources
Signals One is ideally suited to handle research use cases involving earlier stage in-vitro assays, later stage in-vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetic studies, stage animal efficacy and safety studies.
Frequently Asked Questions (FAQs)
In what ways does the Signals One support the development of new drug modalities?
Signals One is designed to handle the complexities associated with developing new drug modalities, such as protein degraders, RNA therapeutics, antibody-drug conjugates (ADCs), next-generation peptides, and gene therapies. It facilitates laboratory workflows, allowing the capture and analysis of diverse data types required for these advanced therapeutics. By providing tools for assay development, hit identification, and lead optimization, Signals One accelerates the drug discovery process for these novel therapeutics.
How does Signals One ensure data security and regulatory compliance?
Signals One implements 24/7 global security monitoring, alerting, and escalation by the Revvity Signals Software Security Operations Center. It supports both multi-tenant and private-cloud deployments and meets standard IT requirements for automatic updates and cloud security controls. The platform also ensures data is findable, accessible, interoperable, and reproducible (FAIR), aiding in data integrity and regulatory compliance.
What benefits does the Signals One offer to scientists?
Benefits include:
- Streamlined collaboration and data sharing across R&D disciplines.
- Accelerates innovation.
- Simplified screening and optimization processes.
- Reduced new product development timelines.
- Better decision-making with easier data sharing.
What makes the Signals One unique compared to other solutions?
Unlike siloed point solutions, Signals One offers a fully integrated platform that encapsulates trusted products, avoiding the complexities and inefficiencies of a piecemeal, application-centric ecosystem. It is the first solution released under the new Revvity Signals Software brand, emphasizing seamless scientific collaboration and data sharing.
Proud Partnerships
